EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. – CRISPR Therapeutics AG Transaction History
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:
$5.51M
portfolio value
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.58% | 4.45K shares | 658K | $65.35 | 84.35K |
| Q2 2022 | share | Increase | +5.05% | 3.84K shares | 81K | $60.77 | 79.9K |
| Q1 2022 | share | Increase | 0.00% | 76.06K shares | 4.77M | $62.77 | 76.06K |